img

Global NSAIDs Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global NSAIDs Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

NSAIDs report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global NSAIDs market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Back Pain Treatment and Osteoarthritis Treatment are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for NSAIDs industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, NSAIDs key manufacturers include Bayer, Novacap, Abbott, Pfizer, Johnson & Johnson, Cigna, Geri-Care Pharmaceuticals, Perrigo Company and Kopran, etc. Bayer, Novacap, Abbott are top 3 players and held % sales share in total in 2022.
NSAIDs can be divided into Aspirin, Ibuprofen, Naproxen and Nabumetone, etc. Aspirin is the mainstream product in the market, accounting for % sales share globally in 2022.
NSAIDs is widely used in various fields, such as Back Pain Treatment, Osteoarthritis Treatment and Other Disease Treatment,, etc. Back Pain Treatment provides greatest supports to the NSAIDs industry development. In 2022, global % sales of NSAIDs went into Back Pain Treatment filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global NSAIDs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Bayer
Novacap
Abbott
Pfizer
Johnson & Johnson
Cigna
Geri-Care Pharmaceuticals
Perrigo Company
Kopran
Merck Sharp & Dohme
Sun Pharmaceutical Industries
GlaxoSmithKline
Reddy Pharmaceuticals
Verywell
Segment by Type
Aspirin
Ibuprofen
Naproxen
Nabumetone
Others

Segment by Application


Back Pain Treatment
Osteoarthritis Treatment
Other Disease Treatment

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the NSAIDs market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of NSAIDs, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the NSAIDs industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of NSAIDs in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, NSAIDs introduction, etc. NSAIDs Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of NSAIDs market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 NSAIDs Market Overview
1.1 NSAIDs Product Overview
1.2 NSAIDs Market Segment by Type
1.2.1 Aspirin
1.2.2 Ibuprofen
1.2.3 Naproxen
1.2.4 Nabumetone
1.2.5 Others
1.3 Global NSAIDs Market Size by Type
1.3.1 Global NSAIDs Market Size Overview by Type (2018-2034)
1.3.2 Global NSAIDs Historic Market Size Review by Type (2018-2024)
1.3.3 Global NSAIDs Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America NSAIDs Sales Breakdown by Type (2018-2024)
1.4.2 Europe NSAIDs Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific NSAIDs Sales Breakdown by Type (2018-2024)
1.4.4 Latin America NSAIDs Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa NSAIDs Sales Breakdown by Type (2018-2024)
2 Global NSAIDs Market Competition by Company
2.1 Global Top Players by NSAIDs Sales (2018-2024)
2.2 Global Top Players by NSAIDs Revenue (2018-2024)
2.3 Global Top Players by NSAIDs Price (2018-2024)
2.4 Global Top Manufacturers NSAIDs Manufacturing Base Distribution, Sales Area, Product Type
2.5 NSAIDs Market Competitive Situation and Trends
2.5.1 NSAIDs Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by NSAIDs Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in NSAIDs as of 2022)
2.7 Date of Key Manufacturers Enter into NSAIDs Market
2.8 Key Manufacturers NSAIDs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 NSAIDs Status and Outlook by Region
3.1 Global NSAIDs Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global NSAIDs Historic Market Size by Region
3.2.1 Global NSAIDs Sales in Volume by Region (2018-2024)
3.2.2 Global NSAIDs Sales in Value by Region (2018-2024)
3.2.3 Global NSAIDs Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global NSAIDs Forecasted Market Size by Region
3.3.1 Global NSAIDs Sales in Volume by Region (2024-2034)
3.3.2 Global NSAIDs Sales in Value by Region (2024-2034)
3.3.3 Global NSAIDs Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global NSAIDs by Application
4.1 NSAIDs Market Segment by Application
4.1.1 Back Pain Treatment
4.1.2 Osteoarthritis Treatment
4.1.3 Other Disease Treatment
4.2 Global NSAIDs Market Size by Application
4.2.1 Global NSAIDs Market Size Overview by Application (2018-2034)
4.2.2 Global NSAIDs Historic Market Size Review by Application (2018-2024)
4.2.3 Global NSAIDs Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America NSAIDs Sales Breakdown by Application (2018-2024)
4.3.2 Europe NSAIDs Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific NSAIDs Sales Breakdown by Application (2018-2024)
4.3.4 Latin America NSAIDs Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa NSAIDs Sales Breakdown by Application (2018-2024)
5 North America NSAIDs by Country
5.1 North America NSAIDs Historic Market Size by Country
5.1.1 North America NSAIDs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America NSAIDs Sales in Volume by Country (2018-2024)
5.1.3 North America NSAIDs Sales in Value by Country (2018-2024)
5.2 North America NSAIDs Forecasted Market Size by Country
5.2.1 North America NSAIDs Sales in Volume by Country (2024-2034)
5.2.2 North America NSAIDs Sales in Value by Country (2024-2034)
6 Europe NSAIDs by Country
6.1 Europe NSAIDs Historic Market Size by Country
6.1.1 Europe NSAIDs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe NSAIDs Sales in Volume by Country (2018-2024)
6.1.3 Europe NSAIDs Sales in Value by Country (2018-2024)
6.2 Europe NSAIDs Forecasted Market Size by Country
6.2.1 Europe NSAIDs Sales in Volume by Country (2024-2034)
6.2.2 Europe NSAIDs Sales in Value by Country (2024-2034)
7 Asia-Pacific NSAIDs by Region
7.1 Asia-Pacific NSAIDs Historic Market Size by Region
7.1.1 Asia-Pacific NSAIDs Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific NSAIDs Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific NSAIDs Sales in Value by Region (2018-2024)
7.2 Asia-Pacific NSAIDs Forecasted Market Size by Region
7.2.1 Asia-Pacific NSAIDs Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific NSAIDs Sales in Value by Region (2024-2034)
8 Latin America NSAIDs by Country
8.1 Latin America NSAIDs Historic Market Size by Country
8.1.1 Latin America NSAIDs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America NSAIDs Sales in Volume by Country (2018-2024)
8.1.3 Latin America NSAIDs Sales in Value by Country (2018-2024)
8.2 Latin America NSAIDs Forecasted Market Size by Country
8.2.1 Latin America NSAIDs Sales in Volume by Country (2024-2034)
8.2.2 Latin America NSAIDs Sales in Value by Country (2024-2034)
9 Middle East and Africa NSAIDs by Country
9.1 Middle East and Africa NSAIDs Historic Market Size by Country
9.1.1 Middle East and Africa NSAIDs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa NSAIDs Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa NSAIDs Sales in Value by Country (2018-2024)
9.2 Middle East and Africa NSAIDs Forecasted Market Size by Country
9.2.1 Middle East and Africa NSAIDs Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa NSAIDs Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Bayer
10.1.1 Bayer Company Information
10.1.2 Bayer Introduction and Business Overview
10.1.3 Bayer NSAIDs Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Bayer NSAIDs Products Offered
10.1.5 Bayer Recent Development
10.2 Novacap
10.2.1 Novacap Company Information
10.2.2 Novacap Introduction and Business Overview
10.2.3 Novacap NSAIDs Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Novacap NSAIDs Products Offered
10.2.5 Novacap Recent Development
10.3 Abbott
10.3.1 Abbott Company Information
10.3.2 Abbott Introduction and Business Overview
10.3.3 Abbott NSAIDs Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Abbott NSAIDs Products Offered
10.3.5 Abbott Recent Development
10.4 Pfizer
10.4.1 Pfizer Company Information
10.4.2 Pfizer Introduction and Business Overview
10.4.3 Pfizer NSAIDs Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Pfizer NSAIDs Products Offered
10.4.5 Pfizer Recent Development
10.5 Johnson & Johnson
10.5.1 Johnson & Johnson Company Information
10.5.2 Johnson & Johnson Introduction and Business Overview
10.5.3 Johnson & Johnson NSAIDs Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Johnson & Johnson NSAIDs Products Offered
10.5.5 Johnson & Johnson Recent Development
10.6 Cigna
10.6.1 Cigna Company Information
10.6.2 Cigna Introduction and Business Overview
10.6.3 Cigna NSAIDs Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Cigna NSAIDs Products Offered
10.6.5 Cigna Recent Development
10.7 Geri-Care Pharmaceuticals
10.7.1 Geri-Care Pharmaceuticals Company Information
10.7.2 Geri-Care Pharmaceuticals Introduction and Business Overview
10.7.3 Geri-Care Pharmaceuticals NSAIDs Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Geri-Care Pharmaceuticals NSAIDs Products Offered
10.7.5 Geri-Care Pharmaceuticals Recent Development
10.8 Perrigo Company
10.8.1 Perrigo Company Company Information
10.8.2 Perrigo Company Introduction and Business Overview
10.8.3 Perrigo Company NSAIDs Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Perrigo Company NSAIDs Products Offered
10.8.5 Perrigo Company Recent Development
10.9 Kopran
10.9.1 Kopran Company Information
10.9.2 Kopran Introduction and Business Overview
10.9.3 Kopran NSAIDs Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Kopran NSAIDs Products Offered
10.9.5 Kopran Recent Development
10.10 Merck Sharp & Dohme
10.10.1 Merck Sharp & Dohme Company Information
10.10.2 Merck Sharp & Dohme Introduction and Business Overview
10.10.3 Merck Sharp & Dohme NSAIDs Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Merck Sharp & Dohme NSAIDs Products Offered
10.10.5 Merck Sharp & Dohme Recent Development
10.11 Sun Pharmaceutical Industries
10.11.1 Sun Pharmaceutical Industries Company Information
10.11.2 Sun Pharmaceutical Industries Introduction and Business Overview
10.11.3 Sun Pharmaceutical Industries NSAIDs Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Sun Pharmaceutical Industries NSAIDs Products Offered
10.11.5 Sun Pharmaceutical Industries Recent Development
10.12 GlaxoSmithKline
10.12.1 GlaxoSmithKline Company Information
10.12.2 GlaxoSmithKline Introduction and Business Overview
10.12.3 GlaxoSmithKline NSAIDs Sales, Revenue and Gross Margin (2018-2024)
10.12.4 GlaxoSmithKline NSAIDs Products Offered
10.12.5 GlaxoSmithKline Recent Development
10.13 Reddy Pharmaceuticals
10.13.1 Reddy Pharmaceuticals Company Information
10.13.2 Reddy Pharmaceuticals Introduction and Business Overview
10.13.3 Reddy Pharmaceuticals NSAIDs Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Reddy Pharmaceuticals NSAIDs Products Offered
10.13.5 Reddy Pharmaceuticals Recent Development
10.14 Verywell
10.14.1 Verywell Company Information
10.14.2 Verywell Introduction and Business Overview
10.14.3 Verywell NSAIDs Sales, Revenue and Gross Margin (2018-2024)
10.14.4 Verywell NSAIDs Products Offered
10.14.5 Verywell Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 NSAIDs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 NSAIDs Industrial Chain Analysis
11.4 NSAIDs Market Dynamics
11.4.1 NSAIDs Industry Trends
11.4.2 NSAIDs Market Drivers
11.4.3 NSAIDs Market Challenges
11.4.4 NSAIDs Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 NSAIDs Distributors
12.3 NSAIDs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Aspirin
Table 2. Major Company of Ibuprofen
Table 3. Major Company of Naproxen
Table 4. Major Company of Nabumetone
Table 5. Major Company of Others
Table 6. Global NSAIDs Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 7. Global NSAIDs Sales by Type (2018-2024) & (K Pcs)
Table 8. Global NSAIDs Sales Market Share in Volume by Type (2018-2024)
Table 9. Global NSAIDs Sales by Type (2018-2024) & (US& Million)
Table 10. Global NSAIDs Market Share in Value by Type (2018-2024)
Table 11. Global NSAIDs Price by Type (2018-2024) & (USD/Pcs)
Table 12. Global NSAIDs Sales by Type (2024-2034) & (K Pcs)
Table 13. Global NSAIDs Sales Market Share in Volume by Type (2024-2034)
Table 14. Global NSAIDs Sales by Type (2024-2034) & (US$ Million)
Table 15. Global NSAIDs Sales Market Share in Value by Type (2024-2034)
Table 16. Global NSAIDs Price by Type (2024-2034) & (USD/Pcs)
Table 17. North America NSAIDs Sales by Type (2018-2024) & (K Pcs)
Table 18. North America NSAIDs Sales by Type (2018-2024) & (US$ Million)
Table 19. Europe NSAIDs Sales (K Pcs) by Type (2018-2024)
Table 20. Europe NSAIDs Sales by Type (2018-2024) & (US$ Million)
Table 21. Asia-Pacific NSAIDs Sales (K Pcs) by Type (2018-2024)
Table 22. Asia-Pacific NSAIDs Sales by Type (2018-2024) & (US$ Million)
Table 23. Latin America NSAIDs Sales (K Pcs) by Type (2018-2024)
Table 24. Latin America NSAIDs Sales by Type (2018-2024) & (US$ Million)
Table 25. Middle East and Africa NSAIDs Sales (K Pcs) by Type (2018-2024)
Table 26. Middle East and Africa NSAIDs Sales by Type (2018-2024) & (US$ Million)
Table 27. Global NSAIDs Sales by Company (2018-2024) & (K Pcs)
Table 28. Global NSAIDs Sales Share by Company (2018-2024)
Table 29. Global NSAIDs Revenue by Company (2018-2024) & (US$ Million)
Table 30. Global NSAIDs Revenue Share by Company (2018-2024)
Table 31. Global Market NSAIDs Price by Company (2018-2024) & (USD/Pcs)
Table 32. Global NSAIDs Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 33. Global NSAIDs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 34. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in NSAIDs as of 2022)
Table 35. Date of Key Manufacturers Enter into NSAIDs Market
Table 36. Key Manufacturers NSAIDs Product Type
Table 37. Mergers & Acquisitions, Expansion Plans
Table 38. Global NSAIDs Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 39. Global NSAIDs Sales by Region (2018-2024) & (K Pcs)
Table 40. Global NSAIDs Sales Market Share in Volume by Region (2018-2024)
Table 41. Global NSAIDs Sales by Region (2018-2024) & (US$ Million)
Table 42. Global NSAIDs Sales Market Share in Value by Region (2018-2024)
Table 43. Global NSAIDs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 44. Global NSAIDs Sales by Region (2024-2034) & (K Pcs)
Table 45. Global NSAIDs Sales Market Share in Volume by Region (2024-2034)
Table 46. Global NSAIDs Sales by Region (2024-2034) & (US$ Million)
Table 47. Global NSAIDs Sales Market Share in Value by Region (2024-2034)
Table 48. Global NSAIDs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2024-2034)
Table 49. Global NSAIDs Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 50. Global NSAIDs Sales by Application (2018-2024) & (K Pcs)
Table 51. Global NSAIDs Sales Market Share in Volume by Application (2018-2024)
Table 52. Global NSAIDs Sales by Application (2018-2024) & (US$ Million)
Table 53. Global NSAIDs Sales Market Share in Value by Application (2018-2024)
Table 54. Global NSAIDs Price by Application (2018-2024) & (USD/Pcs)
Table 55. Global NSAIDs Sales by Application (2024-2034) & (K Pcs)
Table 56. Global NSAIDs Sales Market Share in Volume by Application (2024-2034)
Table 57. Global NSAIDs Sales by Application (2024-2034) & (US$ Million)
Table 58. Global NSAIDs Sales Market Share in Value by Application (2024-2034)
Table 59. Global NSAIDs Price by Application (2024-2034) & (USD/Pcs)
Table 60. North America NSAIDs Sales by Application (2018-2024) (K Pcs)
Table 61. North America NSAIDs Sales by Application (2018-2024) & (US$ Million)
Table 62. Europe NSAIDs Sales by Application (2018-2024) (K Pcs)
Table 63. Europe NSAIDs Sales by Application (2018-2024) & (US$ Million)
Table 64. Asia-Pacific NSAIDs Sales by Application (2018-2024) (K Pcs)
Table 65. Asia-Pacific NSAIDs Sales by Application (2018-2024) & (US$ Million)
Table 66. Latin America NSAIDs Sales by Application (2018-2024) (K Pcs)
Table 67. Latin America NSAIDs Sales by Application (2018-2024) & (US$ Million)
Table 68. Middle East and Africa NSAIDs Sales by Application (2018-2024) (K Pcs)
Table 69. Middle East and Africa NSAIDs Sales by Application (2018-2024) & (US$ Million)
Table 70. North America NSAIDs Sales by Country (2018-2024) & (K Pcs)
Table 71. North America NSAIDs Sales Market Share in Volume by Country (2018-2024)
Table 72. North America NSAIDs Sales by Country (2018-2024) & (US$ Million)
Table 73. North America NSAIDs Sales Market Share in Value by Country (2018-2024)
Table 74. North America NSAIDs Sales by Country (2024-2034) & (K Pcs)
Table 75. North America NSAIDs Sales Market Share in Volume by Country (2024-2034)
Table 76. North America NSAIDs Sales by Country (2024-2034) & (US$ Million)
Table 77. North America NSAIDs Sales Market Share in Value by Country (2024-2034)
Table 78. Europe NSAIDs Sales by Country (2018-2024) & (K Pcs)
Table 79. Europe NSAIDs Sales Market Share in Volume by Country (2018-2024)
Table 80. Europe NSAIDs Sales by Country (2018-2024) & (US$ Million)
Table 81. Europe NSAIDs Sales Market Share in Value by Country (2018-2024)
Table 82. Europe NSAIDs Sales by Country (2024-2034) & (K Pcs)
Table 83. Europe NSAIDs Sales Market Share in Volume by Country (2024-2034)
Table 84. Europe NSAIDs Sales by Country (2024-2034) & (US$ Million)
Table 85. Europe NSAIDs Sales Market Share in Value by Country (2024-2034)
Table 86. Asia-Pacific NSAIDs Sales by Region (2018-2024) & (K Pcs)
Table 87. Asia-Pacific NSAIDs Sales Market Share in Volume by Region (2018-2024)
Table 88. Asia-Pacific NSAIDs Sales by Region (2018-2024) & (US$ Million)
Table 89. Asia-Pacific NSAIDs Sales Market Share in Value by Region (2018-2024)
Table 90. Asia-Pacific NSAIDs Sales by Region (2024-2034) & (K Pcs)
Table 91. Asia-Pacific NSAIDs Sales Market Share in Volume by Region (2024-2034)
Table 92. Asia-Pacific NSAIDs Sales by Region (2024-2034) & (US$ Million)
Table 93. Asia-Pacific NSAIDs Sales Market Share in Value by Region (2024-2034)
Table 94. Latin America NSAIDs Sales by Country (2018-2024) & (K Pcs)
Table 95. Latin America NSAIDs Sales Market Share in Volume by Country (2018-2024)
Table 96. Latin America NSAIDs Sales by Country (2018-2024) & (US$ Million)
Table 97. Latin America NSAIDs Sales Market Share in Value by Country (2018-2024)
Table 98. Latin America NSAIDs Sales by Country (2024-2034) & (K Pcs)
Table 99. Latin America NSAIDs Sales Market Share in Volume by Country (2024-2034)
Table 100. Latin America NSAIDs Sales by Country (2024-2034) & (US$ Million)
Table 101. Latin America NSAIDs Sales Market Share in Value by Country (2024-2034)
Table 102. Middle East and Africa NSAIDs Sales by Country (2018-2024) & (K Pcs)
Table 103. Middle East and Africa NSAIDs Sales Market Share in Volume by Country (2018-2024)
Table 104. Middle East and Africa NSAIDs Sales by Country (2018-2024) & (US$ Million)
Table 105. Middle East and Africa NSAIDs Sales Market Share in Value by Country (2018-2024)
Table 106. Middle East and Africa NSAIDs Sales by Country (2024-2034) & (K Pcs)
Table 107. Middle East and Africa NSAIDs Sales Market Share in Volume by Country (2024-2034)
Table 108. Middle East and Africa NSAIDs Sales by Country (2024-2034) & (US$ Million)
Table 109. Middle East and Africa NSAIDs Sales Market Share in Value by Country (2024-2034)
Table 110. Bayer Company Information
Table 111. Bayer Introduction and Business Overview
Table 112. Bayer NSAIDs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 113. Bayer NSAIDs Product
Table 114. Bayer Recent Development
Table 115. Novacap Company Information
Table 116. Novacap Introduction and Business Overview
Table 117. Novacap NSAIDs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 118. Novacap NSAIDs Product
Table 119. Novacap Recent Development
Table 120. Abbott Company Information
Table 121. Abbott Introduction and Business Overview
Table 122. Abbott NSAIDs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 123. Abbott NSAIDs Product
Table 124. Abbott Recent Development
Table 125. Pfizer Company Information
Table 126. Pfizer Introduction and Business Overview
Table 127. Pfizer NSAIDs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 128. Pfizer NSAIDs Product
Table 129. Pfizer Recent Development
Table 130. Johnson & Johnson Company Information
Table 131. Johnson & Johnson Introduction and Business Overview
Table 132. Johnson & Johnson NSAIDs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 133. Johnson & Johnson NSAIDs Product
Table 134. Johnson & Johnson Recent Development
Table 135. Cigna Company Information
Table 136. Cigna Introduction and Business Overview
Table 137. Cigna NSAIDs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 138. Cigna NSAIDs Product
Table 139. Cigna Recent Development
Table 140. Geri-Care Pharmaceuticals Company Information
Table 141. Geri-Care Pharmaceuticals Introduction and Business Overview
Table 142. Geri-Care Pharmaceuticals NSAIDs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 143. Geri-Care Pharmaceuticals NSAIDs Product
Table 144. Geri-Care Pharmaceuticals Recent Development
Table 145. Perrigo Company Company Information
Table 146. Perrigo Company Introduction and Business Overview
Table 147. Perrigo Company NSAIDs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 148. Perrigo Company NSAIDs Product
Table 149. Perrigo Company Recent Development
Table 150. Kopran Company Information
Table 151. Kopran Introduction and Business Overview
Table 152. Kopran NSAIDs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 153. Kopran NSAIDs Product
Table 154. Kopran Recent Development
Table 155. Merck Sharp & Dohme Company Information
Table 156. Merck Sharp & Dohme Introduction and Business Overview
Table 157. Merck Sharp & Dohme NSAIDs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 158. Merck Sharp & Dohme NSAIDs Product
Table 159. Merck Sharp & Dohme Recent Development
Table 160. Sun Pharmaceutical Industries Company Information
Table 161. Sun Pharmaceutical Industries Introduction and Business Overview
Table 162. Sun Pharmaceutical Industries NSAIDs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 163. Sun Pharmaceutical Industries NSAIDs Product
Table 164. Sun Pharmaceutical Industries Recent Development
Table 165. GlaxoSmithKline Company Information
Table 166. GlaxoSmithKline Introduction and Business Overview
Table 167. GlaxoSmithKline NSAIDs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 168. GlaxoSmithKline NSAIDs Product
Table 169. GlaxoSmithKline Recent Development
Table 170. Reddy Pharmaceuticals Company Information
Table 171. Reddy Pharmaceuticals Introduction and Business Overview
Table 172. Reddy Pharmaceuticals NSAIDs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 173. Reddy Pharmaceuticals NSAIDs Product
Table 174. Reddy Pharmaceuticals Recent Development
Table 175. Verywell Company Information
Table 176. Verywell Introduction and Business Overview
Table 177. Verywell NSAIDs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 178. Verywell NSAIDs Product
Table 179. Verywell Recent Development
Table 180. Key Raw Materials Lists
Table 181. Raw Materials Key Suppliers Lists
Table 182. NSAIDs Market Trends
Table 183. NSAIDs Market Drivers
Table 184. NSAIDs Market Challenges
Table 185. NSAIDs Market Restraints
Table 186. NSAIDs Distributors List
Table 187. NSAIDs Downstream Customers
Table 188. Research Programs/Design for This Report
Table 189. Key Data Information from Secondary Sources
Table 190. Key Data Information from Primary Sources
List of Figures
Figure 1. NSAIDs Product Picture
Figure 2. Global NSAIDs Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global NSAIDs Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global NSAIDs Sales Status and Outlook (2018-2034) & (K Pcs)
Figure 5. Product Picture of Aspirin
Figure 6. Global Aspirin Sales YoY Growth (2018-2034) & (K Pcs)
Figure 7. Product Picture of Ibuprofen
Figure 8. Global Ibuprofen Sales YoY Growth (2018-2034) & (K Pcs)
Figure 9. Product Picture of Naproxen
Figure 10. Global Naproxen Sales YoY Growth (2018-2034) & (K Pcs)
Figure 11. Product Picture of Nabumetone
Figure 12. Global Nabumetone Sales YoY Growth (2018-2034) & (K Pcs)
Figure 13. Product Picture of Others
Figure 14. Global Others Sales YoY Growth (2018-2034) & (K Pcs)
Figure 15. Global NSAIDs Sales by Type (2018-2034) & (US$ Million)
Figure 16. Global NSAIDs Sales Market Share by Type in 2022 & 2034
Figure 17. North America NSAIDs Sales Market Share in Volume by Type in 2022
Figure 18. North America NSAIDs Sales Market Share in Value by Type in 2022
Figure 19. Europe NSAIDs Sales Market Share in Volume by Type in 2022
Figure 20. Europe NSAIDs Sales Market Share in Value by Type in 2022
Figure 21. Asia-Pacific NSAIDs Sales Market Share in Volume by Type in 2022
Figure 22. Asia-Pacific NSAIDs Sales Market Share in Value by Type in 2022
Figure 23. Latin America NSAIDs Sales Market Share in Volume by Type in 2022
Figure 24. Latin America NSAIDs Sales Market Share in Value by Type in 2022
Figure 25. Middle East and Africa NSAIDs Sales Market Share in Volume by Type in 2022
Figure 26. Middle East and Africa NSAIDs Sales Market Share in Value by Type in 2022
Figure 27. The 5 and 10 Largest Manufacturers in the World: Market Share by NSAIDs Sales in 2022
Figure 28. The 5 and 10 Largest Manufacturers in the World: Market Share by NSAIDs Revenue in 2022
Figure 29. NSAIDs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Product Picture of Back Pain Treatment
Figure 31. Global Back Pain Treatment Sales YoY Growth (2018-2034) & (K Pcs)
Figure 32. Product Picture of Osteoarthritis Treatment
Figure 33. Global Osteoarthritis Treatment Sales YoY Growth (2018-2034) & (K Pcs)
Figure 34. Product Picture of Other Disease Treatment
Figure 35. Global Other Disease Treatment Sales YoY Growth (2018-2034) & (K Pcs)
Figure 36. Global NSAIDs Sales by Application (2018-2034) & (US$ Million)
Figure 37. Global NSAIDs Sales Market Share by Application in 2022 & 2034
Figure 38. North America NSAIDs Sales Market Share in Volume by Application in 2022
Figure 39. North America NSAIDs Sales Market Share in Value by Application in 2022
Figure 40. Europe NSAIDs Sales Market Share in Volume by Application in 2022
Figure 41. Europe NSAIDs Sales Market Share in Value by Application in 2022
Figure 42. Asia-Pacific NSAIDs Sales Market Share in Volume by Application in 2022
Figure 43. Asia-Pacific NSAIDs Sales Market Share in Value by Application in 2022
Figure 44. Latin America NSAIDs Sales Market Share in Volume by Application in 2022
Figure 45. Latin America NSAIDs Sales Market Share in Value by Application in 2022
Figure 46. Middle East and Africa NSAIDs Sales Market Share in Value by Application in 2022
Figure 47. Key Raw Materials Price
Figure 48. NSAIDs Manufacturing Cost Structure
Figure 49. NSAIDs Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed